Ingredient news
EFSA Opinion Clears L-Alpha-GPC From Soya Phospholipids for Supplement Use
By Nutranexa News |
EFSA's latest novel-food opinion says L-alpha-GPC made from soya phospholipids is safe for food-supplement use at the proposed maximum intake, adding a fresh regulatory reference point for choline suppliers.
What EFSA Assessed
EFSA evaluated L-alpha-glycerylphosphorylcholine from soya phospholipids as a novel food under the EU novel food framework, treating it as a choline source derived from lecithin-linked raw material.
The published opinion describes L-alpha-GPC as an endogenous metabolite of phosphatidylcholine that is rapidly absorbed and serves as a source of choline.
Key Use Conditions
According to the opinion summary, the proposed use is in food supplements at up to 203.7 mg per day, corresponding to 82.5 mg per day of choline.
The target population is the general population excluding infants, and EFSA concluded that the novel food is safe under those proposed conditions.
Buyer Takeaway
For choline and phospholipid suppliers, the opinion is commercially relevant because it gives EU-facing teams a current regulatory benchmark on source route, use level, and target population.
Buyers should still review destination-market labeling, finished-product positioning, and supplier specification control rather than assuming an opinion alone resolves every commercial question.